Crombez Eric
Insider CIK 1653052 · RARE EVP and Chief Medical Officer · DMTX Chief Medical Officer · ABEO Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ABEO ABEONA THERAPEUTICS INC. | S Sale | 2026-05-15 | 2026-05-15 | 26,143 | $5.53 | $144.6K | 37,313 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2026-05-05 | 2026-05-06 | 344 | $24.96 | $8.6K | 111,189 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2026-04-16 | 2026-04-20 | 59,952 | — | $0 | 59,952 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2026-04-16 | 2026-04-20 | 34,674 | — | $0 | 110,975 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2026-03-02 | 2026-03-03 | 7,029 | $22.80 | $160.3K | 76,301 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2026-03-01 | 2026-03-03 | 11,643 | — | $0 | 83,173 | SEC↗ |
| ABEO ABEONA THERAPEUTICS INC. | S Sale | 2026-02-02 | 2026-02-02 | 16,284 | $5.09 | $82.9K | 63,456 | SEC↗ |
| ABEO ABEONA THERAPEUTICS INC. | A Award | 2026-01-26 | 2026-01-27 | 37,313 | — | $0 | 79,740 | SEC↗ |
| ABEO ABEONA THERAPEUTICS INC. | S Sale | 2025-08-14 | 2025-08-15 | 4,718 | $6.93 | $32.7K | 42,427 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2025-05-05 | 2025-05-05 | 520 | $39.24 | $20.4K | 71,530 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2025-04-21 | 2025-05-05 | 242 | $35.11 | $8.5K | 71,680 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2025-03-03 | 2025-03-04 | 8,945 | $42.10 | $376.6K | 71,922 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2025-03-01 | 2025-03-04 | 30,246 | — | $0 | 30,246 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2025-03-01 | 2025-03-04 | 16,813 | — | $0 | 65,244 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2025-03-01 | 2025-03-04 | 14,971 | — | $0 | 80,215 | SEC↗ |
| ABEO ABEONA THERAPEUTICS INC. | A Award | 2025-01-31 | 2025-02-03 | 36,101 | — | $0 | 47,145 | SEC↗ |
| ABEO ABEONA THERAPEUTICS INC. | A Award | 2024-08-13 | 2024-08-14 | 11,044 | — | $0 | 11,044 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2024-05-02 | 2024-05-03 | 354 | $43.66 | $15.5K | 48,431 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2024-04-18 | 2024-04-19 | 142 | $44.10 | $6.3K | 48,785 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2024-03-01 | 2024-03-05 | 2,351 | — | $0 | 2,351 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2024-03-01 | 2024-03-05 | 34,200 | — | $0 | 34,200 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2024-03-01 | 2024-03-05 | 1,238 | $53.76 | $66.6K | 48,927 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2024-03-01 | 2024-03-05 | 19,400 | — | $0 | 49,912 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2023-09-27 | 2023-09-29 | 2,351 | — | $0 | 2,351 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2023-05-01 | 2023-05-02 | 8,362 | — | $0 | 8,362 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2023-05-01 | 2023-05-02 | 4,658 | — | $0 | 30,512 | SEC↗ |
| DMTX Dimension Therapeutics, In | D To issuer deriv | 2017-11-07 | 2017-11-07 | 80,396 | — | $0 | 0 | SEC↗ |
| DMTX Dimension Therapeutics, In | D To issuer deriv | 2017-11-07 | 2017-11-07 | 50,000 | — | $0 | 0 | SEC↗ |
| DMTX Dimension Therapeutics, In | D To issuer deriv | 2017-11-07 | 2017-11-07 | 128,292 | — | $0 | 0 | SEC↗ |
| DMTX Dimension Therapeutics, In | D To issuer deriv | 2017-11-07 | 2017-11-07 | 50,000 | — | $0 | 0 | SEC↗ |
| DMTX Dimension Therapeutics, In | A Award deriv | 2017-02-01 | 2017-02-03 | 50,000 | — | $0 | 50,000 | SEC↗ |
| DMTX Dimension Therapeutics, In | A Award deriv | 2016-02-01 | 2016-02-02 | 50,000 | — | $0 | 50,000 | SEC↗ |